Stock listing

OTC:NXEN Nexien BioPharma, Inc. Stock

Follow Nexien BioPharma, Inc. into a list and get an email when it puts out news.

Share price · OTC:NXEN

$0.0001 USD 0.0000 (0.0%)

Close on Oct 14, 2026 · Data provided by Twelve Data

Nexien BioPharma, Inc. logo
Ticker
OTC:NXEN
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
OTC
Currency
USD

Latest news

Nexien BioPharma, Inc. Engages CORE IR for Investor Relations, Public Relations and Shareholder Communications Services

Feb 19, 2021

Nexien BioPharma, Inc. Has Been Issued a U.S. Patent for the Methods and Compositions for Treating Non-Dystrophic Myotonia and Myotonic Dystrophies Types 1 and 2

Jul 16, 2020

Nexien BioPharma announces that it has been granted a patent by the Israeli Patent Office covering the use of cannabinoids and terpenes for treatment of organophosphate and carbamate toxicity - two common nerve agents

Jul 18, 2019

Nexien BioPharma to Present at The MicroCap Conference Spring Investor Summit on Tuesday, April 2nd

Mar 28, 2019

Nexien BioPharma Announces Acceptance of Patent Application No. 238946 by Israeli Patent Office

Mar 5, 2019

Nexien BioPharma to File Pre-IND Meeting Request with the FDA

Feb 26, 2019

Nexien BioPharma Announces Executive and Business Updates

Feb 19, 2019

Nexien BioPharma Releases Letter to Shareholders Announcing 2019 Plans, 2018 Activities, and Work to Come From Acquisitions

Dec 6, 2018

Nexien BioPharma And Ivy League University Medical School Collaborate On Pre-Clinical Cannabinoid Studies

Nov 28, 2018

Uptick Newswire's Stock Day Podcast Interviews Nexien BioPharma CEO, Alex Wasyl, to Discuss the Acquisition of CRX Bio Holdings and The Company’s Future in The Pharmaceutical Space

Nov 26, 2018

All Nexien BioPharma, Inc. news

Decks

Nexien BioPharma, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
17 in all · newest Feb 19, 2021 · oldest 2018
Decks
1 deck · latest Mar 8, 2019

Log in to ask 6ix AI your own questions about Nexien BioPharma, Inc.